ReutersCodex · 实盘不做把握 8/10
北京时间·🕒 发布 19:09:54时区推断·⟳ 抓取 19:11:00·⚡ 决策 07-23 21:28:14 +2h17m·95.8 天前
MercadoLibre拟在智利推进自营线上药房但仍需监管放行
这只是MercadoLibre与智利监管沟通自营线上药房方案，当前法规尚不允许线上-only药房，尚未形成获批、上线或可量化收入增量。
📄 原文Reuters↗ 原文
E-commerce firm MercadoLibre (MELI.O) has discussed a proposal with Chilean authorities to operate as a pharmacy in the…
不做 MercadoLibre（MELI.US）
计划仍需智利监管修改或重新解释规则，且智利市场和早期药房试点相对MELI体量太小，当前没有可执行短线edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-23 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是MercadoLibre与智利监管沟通自营线上药房方案，当前法规尚不允许线上-only药房，尚未形成获批、上线或可量化收入增量。
- 智利不是MercadoLibre核心市场，且药房业务仍处早期试点阶段，相对公司体量短线重大性不足。
主要风险
- 若后续智利监管正式修改规则并批准上线，可能成为拉美药房业务扩张的增量催化，需要新信号再评估。
原文全文
展开原文 · 2,796 字
E-commerce firm MercadoLibre (MELI.O) has discussed a proposal with Chilean authorities to operate as a pharmacy in the country, a plan that would require a change in local regulations, records of meetings between the parties showed.
The move would mark the latest step by Uruguay-based MercadoLibre, once primarily a marketplace for external sellers, toward expanding its own retail operations while deepening its push into pharmacies after a similar pilot in Brazil.
MercadoLibre, which operates across Latin America and is one of the region's largest firms by market capitalization, met with Chilean officials at least six times in the past year. Meeting minutes revealed MercadoLibre's previously unreported plan to operate an in-house and online-only pharmacy model in Chile.
The plan would expand the firm's Chile operations, where, as in Argentina, Mexico and other markets, MercadoLibre currently only sells medication from third-party retailers.
After hearing the plan, Chile's health ministry recommended that MercadoLibre seek a technical evaluation from the nation's Public Health Institute (ISP), since the proposal would require regulatory changes or reinterpretations, according to records from a January meeting.
ISP in a written response to a request for comment did not detail whether MercadoLibre had requested that evaluation. It said MercadoLibre currently does not have authorization to operate an in-house drugstore in Chile, and that current regulations do not allow for the operation of an online-only drugstore.
Chile's health ministry did not respond to requests for comment.
MercadoLibre said in a statement to Reuters that it was working to gradually expand its health offering, adapting to each market's regulatory framework. It declined to comment specifically on plans in Chile.
As part of a broader long-term business strategy, the firm has increased investment in its in-house retail operations in recent quarters, focusing on segments such as beauty and household appliances.
That strategy has pressured margins, causing the stock to tumble almost 11% so far this year to $1,799 each.
In Brazil, its biggest market, MercadoLibre bought a physical drugstore last year due to local rules requiring a brick-and-mortar presence for companies selling medicines. It began a pilot there in March selling over-the-counter medicines, promising delivery in an average of up to three hours. It has yet to expand outside of Sao Paulo.
The firm's pitch in Chile also included deliveries in "a few hours in some regions," according to minutes from a meeting in September.
Chile lags behind the company's largest markets of Brazil, Mexico and Argentina, but a successful rollout there could serve as a model for expansion across Latin America.
The move would mark the latest step by Uruguay-based MercadoLibre, once primarily a marketplace for external sellers, toward expanding its own retail operations while deepening its push into pharmacies after a similar pilot in Brazil.
MercadoLibre, which operates across Latin America and is one of the region's largest firms by market capitalization, met with Chilean officials at least six times in the past year. Meeting minutes revealed MercadoLibre's previously unreported plan to operate an in-house and online-only pharmacy model in Chile.
The plan would expand the firm's Chile operations, where, as in Argentina, Mexico and other markets, MercadoLibre currently only sells medication from third-party retailers.
After hearing the plan, Chile's health ministry recommended that MercadoLibre seek a technical evaluation from the nation's Public Health Institute (ISP), since the proposal would require regulatory changes or reinterpretations, according to records from a January meeting.
ISP in a written response to a request for comment did not detail whether MercadoLibre had requested that evaluation. It said MercadoLibre currently does not have authorization to operate an in-house drugstore in Chile, and that current regulations do not allow for the operation of an online-only drugstore.
Chile's health ministry did not respond to requests for comment.
MercadoLibre said in a statement to Reuters that it was working to gradually expand its health offering, adapting to each market's regulatory framework. It declined to comment specifically on plans in Chile.
As part of a broader long-term business strategy, the firm has increased investment in its in-house retail operations in recent quarters, focusing on segments such as beauty and household appliances.
That strategy has pressured margins, causing the stock to tumble almost 11% so far this year to $1,799 each.
In Brazil, its biggest market, MercadoLibre bought a physical drugstore last year due to local rules requiring a brick-and-mortar presence for companies selling medicines. It began a pilot there in March selling over-the-counter medicines, promising delivery in an average of up to three hours. It has yet to expand outside of Sao Paulo.
The firm's pitch in Chile also included deliveries in "a few hours in some regions," according to minutes from a meeting in September.
Chile lags behind the company's largest markets of Brazil, Mexico and Argentina, but a successful rollout there could serve as a model for expansion across Latin America.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。